These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Prospective study of aflibercept for the treatment of persistent macular oedema secondary to retinal vein occlusions in eyes not responsive to long-term treatment with bevacizumab or ranibizumab. Spooner K; Fraser-Bell S; Hong T; Chang A Clin Exp Ophthalmol; 2020 Jan; 48(1):53-60. PubMed ID: 31498950 [TBL] [Abstract][Full Text] [Related]
9. Five-year visual acuity outcomes and injection patterns in patients with pro-re-nata treatments for AMD, DME, RVO and myopic CNV. Wecker T; Ehlken C; Bühler A; Lange C; Agostini H; Böhringer D; Stahl A Br J Ophthalmol; 2017 Mar; 101(3):353-359. PubMed ID: 27215744 [TBL] [Abstract][Full Text] [Related]
10. Management and Outcomes for Neovascular Age-Related Macular Degeneration: Analysis of United States Electronic Health Records. Kiss S; Campbell J; Almony A; Shih V; Serbin M; LaPrise A; Wykoff CC Ophthalmology; 2020 Sep; 127(9):1179-1188. PubMed ID: 32345477 [TBL] [Abstract][Full Text] [Related]
17. Individualized treat-and-extend regime for optimization of real-world vision outcome and improved patients' persistence. Volkmann I; Knoll K; Wiezorrek M; Greb O; Framme C BMC Ophthalmol; 2020 Mar; 20(1):122. PubMed ID: 32228517 [TBL] [Abstract][Full Text] [Related]
18. [Efficacy of three intravitreal injections of bevacizumab in the treatment of exudative age-related macular degeneration]. Bidot ML; Malvitte L; Bidot S; Bron A; Creuzot-Garcher C J Fr Ophtalmol; 2011 Jun; 34(6):376-81. PubMed ID: 21550687 [TBL] [Abstract][Full Text] [Related]
19. Twelve-month safety of intravitreal injections of bevacizumab (Avastin): results of the Pan-American Collaborative Retina Study Group (PACORES). Wu L; Martínez-Castellanos MA; Quiroz-Mercado H; Arevalo JF; Berrocal MH; Farah ME; Maia M; Roca JA; Rodriguez FJ; Graefes Arch Clin Exp Ophthalmol; 2008 Jan; 246(1):81-7. PubMed ID: 17674014 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of Month-24 Efficacy and Safety of Epimacular Brachytherapy for Previously Treated Neovascular Age-Related Macular Degeneration: The MERLOT Randomized Clinical Trial. Jackson TL; Soare C; Petrarca C; Simpson A; Neffendorf JE; Petrarca R; Muldrew A; Peto T; Chakravarthy U; Membrey L; Haynes R; Costen M; Steel D; Desai R; JAMA Ophthalmol; 2020 Aug; 138(8):835-842. PubMed ID: 32644148 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]